-
-
-
-
-
-
-
Stifel on Soleno Therapeutics (SLNO): 'We think SLNO's pre-print is overall solid'
-
-
-
-
-
-
-
Piper Sandler on Soleno Therapeutics Inc. (SLNO): 'Why We Remain Bullish on VYKAT XR Launch'
-
-
-
-
-
-
-
Wells Fargo on Soleno Therapeutics Inc. (SLNO): 'We Think Shares Should Trade Up at Least +20% on ACAD Failure'
-
-
-
-
-
-
-
Soleno Therapeutics (SLNO) Falls 17%
-
-
-
-
-
-
-
Soleno Therapeutics Inc. (SLNO) PT Raised to $110 at H.C. Wainwright
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)
-
-
-
-
-
-
-
Piper Sandler on Soleno Therapeutics Inc. (SLNO): 'VYKAT XR PWS Launch Is Destined for Success'
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

